Home Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking
Article
Licensed
Unlicensed Requires Authentication

Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking

  • Altan Onat , Gülay Hergenç , Mehmet Agırbaşlı , Zekeriya Kaya , Günay Can and Nihan E. Ünaltuna
Published/Copyright: February 1, 2009

Abstract

Background: Correlates of preheparin serum lipoprotein lipase (LPL) mass and its associations with the likelihood of metabolic syndrome (MS) and coronary heart disease (CHD) were investigated.

Methods: A cross-sectional study was carried out in a population sample (n=352, median age 55). MS was defined according to modified Adult Treatment Panel III criteria.

Results: Age-adjusted geometric mean preheparin LPL concentrations were 58.6±1.04 ng/mL in men and 66.9±1.03 ng/mL in women (p<0.004). A positive interaction with both the LPL X447 allele (p<0.034) and age-adjusted smoking status (p=0.026 in men and p=0.11 women) was observed. LPL mass was significantly correlated in both genders with high-density lipoprotein (HDL)-cholesterol and inversely with triacylglycerol levels and HOMA index. In multiple linear regression analysis, LPL mass was significantly associated with genotype, gender, age, adiponectin, smoking status and HDL-cholesterol, and in women with C-reactive protein after adjustment for body mass index, triacylglycerol and insulin. Significantly low sex- and age-adjusted serum LPL mass was observed in cases of MS, hypertension and CHD. Logistic regression analysis after adjustment for age, sex, adiponectin and S447X polymorphism demonstrated that LPL mass was inversely associated with CHD in men and both genders (p=0.02), with hypertension confined to women (p=0.04) and with MS likelihood in both genders combined and women [odds ratio 1.51 (95% CI 1.14–2.00) for halving the likelihood].

Conclusions: LPL X447 genotype, female gender and smoking habit interact in increasing preheparin serum LPL mass in Turkish adults. Serum LPL mass is inversely associated with MS and CHD, independent of confounders, and probably reflects insulin sensitivity.

Clin Chem Lab Med 2009;47:208–15.


Corresponding author: Prof. Dr. Altan Onat, Nisbetiye cad. 37/24, Etiler 34335, Istanbul, Turkey Phone: +90-212-3516217, Fax: +90-212-3514235,

Received: 2008-5-6
Accepted: 2008-6-4
Published Online: 2009-02-01
Published in Print: 2009-02-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. 50th Anniversary of SBCC/BVKC: “International Symposium Brussels 2008: New Trends in Clinical Biology. Emerging Technologies and their Impact on Laboratory Medicine and Management”
  3. Reviews
  4. Vitamin D: current status and perspectives
  5. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
  6. New European guidelines for cardiovascular disease prevention in clinical practice
  7. Review
  8. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics
  9. Genetics and Molecular Diagnostics
  10. The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan
  11. Polymorphisms and plasma soluble levels of E-selectin in patients with chronic hepatitis B virus infection
  12. General Clinical Chemistry and Laboratory Medicine
  13. Effect of high levels of human chorionic gonadotropin and estradiol on the severity of hyperemesis gravidarum
  14. Freeze-thaw and matrix effects in direct high-density lipoprotein cholesterol methods
  15. Methodology for monitoring cytomegalovirus infection after renal transplantation
  16. High concentrations of haptocorrin interfere with routine measurement of cobalamins in human serum and milk. A problem and its solution
  17. Reference Values and Biological Variations
  18. Inter- and intra-individual variations of urinary endogenous metabolites in healthy male college students using 1H NMR spectroscopy
  19. Preanalytical errors in primary healthcare: a questionnaire study of information search procedures, test request management and test tube labelling
  20. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female
  21. Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking
  22. Validation and Outcome Studies
  23. Comparison of calcium, magnesium, sodium, potassium, zinc, and creatinine concentration in 24-h and spot urine samples in women
  24. Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands
  25. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study
  26. Letters to the Editor
  27. Interference of IgM-λ paraprotein with biuret-type assay for total serum protein quantification
  28. Evaluation of BD Vacutainer® PST™II tubes for a wide range of immunoassays
  29. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.018/html
Scroll to top button